319 related articles for article (PubMed ID: 30617873)
1. Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis.
Lu Y; Chen Y; Zhu L; Cartwright P; Song E; Jacobs L; Chen K
Ann Surg Oncol; 2019 May; 26(5):1263-1275. PubMed ID: 30617873
[TBL] [Abstract][Full Text] [Related]
2. The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08).
Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
Clin Breast Cancer; 2019 Oct; 19(5):345-353.e2. PubMed ID: 31103280
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
[TBL] [Abstract][Full Text] [Related]
4. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
5. Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08).
Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
Breast Cancer Res Treat; 2018 Sep; 171(2):335-344. PubMed ID: 29808288
[TBL] [Abstract][Full Text] [Related]
6. Surgical management in phyllodes tumors of the breast: a systematic review and meta-analysis.
Wei Y; Yu Y; Ji Y; Zhong Y; Min N; Hu H; Guan Q; Li X
Gland Surg; 2022 Mar; 11(3):513-523. PubMed ID: 35402210
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
[TBL] [Abstract][Full Text] [Related]
8. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast.
Jang JH; Choi MY; Lee SK; Kim S; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Cho EY; Lee JE; Nam SJ; Yang JH
Ann Surg Oncol; 2012 Aug; 19(8):2612-7. PubMed ID: 22476816
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast.
Barrio AV; Clark BD; Goldberg JI; Hoque LW; Bernik SF; Flynn LW; Susnik B; Giri D; Polo K; Patil S; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2961-70. PubMed ID: 17562113
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.
Spanheimer PM; Murray MP; Zabor EC; Stempel M; Morrow M; Van Zee KJ; Barrio AV
Ann Surg Oncol; 2019 Jul; 26(7):2136-2143. PubMed ID: 30783853
[TBL] [Abstract][Full Text] [Related]
12. Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis.
Sawalhi S; Al-Shatti M
Ann Saudi Med; 2013; 33(2):162-8. PubMed ID: 23563006
[TBL] [Abstract][Full Text] [Related]
13. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
[TBL] [Abstract][Full Text] [Related]
14. Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study.
Borhani-Khomani K; Talman ML; Kroman N; Tvedskov TF
Ann Surg Oncol; 2016 May; 23(5):1543-8. PubMed ID: 26714948
[TBL] [Abstract][Full Text] [Related]
15. Histological Risk Factors for Local Recurrence of Phyllodes Tumors of the Breast.
Mimoun C; Legay L; Lorphelin H; Leveau-Vallier AS; Cornelis F; Miquel C; Marchand E; Mezzadri M; Teixeira L; Cahen-Doidy L; Huchon C
Anticancer Res; 2023 Jan; 43(1):143-147. PubMed ID: 36585183
[TBL] [Abstract][Full Text] [Related]
16. Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines.
Rosenberger LH; Thomas SM; Nimbkar SN; Hieken TJ; Ludwig KK; Jacobs LK; Miller ME; Gallagher KK; Wong J; Neuman HB; Tseng J; Hassinger TE; King TA; Jakub JW
J Clin Oncol; 2021 Jan; 39(3):178-189. PubMed ID: 33301374
[TBL] [Abstract][Full Text] [Related]
17. Repeat recurrence and malignant transition of phyllodes tumors of the breast.
Wada A; Hayashi N; Endo F; Tsunoda H; Yoshida A; Suzuki K; Nakamura S; Yamauchi H
Breast Cancer; 2018 Nov; 25(6):736-741. PubMed ID: 29951882
[TBL] [Abstract][Full Text] [Related]
18. Recurrence prediction for breast phyllodes tumours: validation of the Singapore nomogram in Korean women.
Choi JE; Kang SH; Tan PH; Bae YK
J Clin Pathol; 2022 Mar; 75(3):159-163. PubMed ID: 33376198
[TBL] [Abstract][Full Text] [Related]
19. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
[TBL] [Abstract][Full Text] [Related]
20. Management of phyllodes tumor: A systematic review and meta-analysis of real-world evidence.
Yu CY; Huang TW; Tam KW
Int J Surg; 2022 Nov; 107():106969. PubMed ID: 36328344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]